The Journal of Urology
Volume 181, Issue 4 , Pages 1530-1531, April 2009

A Guideline for Discussion and Some Thoughts

published online 26 February 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(09)00169-4

doi:10.1016/j.juro.2009.01.068

Refers to article:

  • Use of 5α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline , 26 February 2009

    Barnett S. Kramer, Karen L. Hagerty, Stewart Justman, Mark R. Somerfield, Peter C. Albertsen, William J. Blot, H. Ballentine Carter, Joseph P. Costantino, Jonathan I. Epstein, Paul A. Godley, Russell P. Harris, Timothy J. Wilt, Janet Wittes, Robin Zon, Paul Schellhammer
    The Journal of Urology April 2009 (Vol. 181, Issue 4, Pages 1642-1657)

The Journal of Urology
Volume 181, Issue 4 , Pages 1530-1531, April 2009

Article Tools